Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
47.74
+0.02 (0.04%)
At close: Sep 26, 2025, 4:00 PM EDT
47.69
-0.05 (-0.10%)
After-hours: Sep 26, 2025, 6:44 PM EDT
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $1.23 billion as of September 26, 2025. Its market cap has increased by 167.60% in one year.
Market Cap
1.23B
Enterprise Value
990.50M
1-Year Change
167.60%
Ranking
Category
Stock Price
$47.74
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $1.23B, an increase of 454.69%. That is a compound annual growth rate of 142.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 1.23B | 136.45% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |